No | Text |
1 | Products |
2 | Responsibility |
No | Text |
1 | About us |
2 | Responsibility |
3 | Products |
4 | ınvestors |
5 | Careers |
No | Text |
1 | Glenmark during the time of covıd-19 |
2 | Dow jones sustainability emerging markets ındex 2019 |
3 | A new way for a new world |
4 | A new world. a healthier world. |
5 | Discovering advance therapies for a new world |
6 | A new way for a new world begins with us |
No | Text |
1 | Glenmark’s consolidated revenue rises by 7.07% to rs. 27,355.61 mn. in q3 fy 2019-20 |
2 | Glenmark’s q3 fy 2019-20 results |
3 | Glenmark’s mda q3 fy 2019 – 20 |
4 | Q3 fy20 earnings call ınvitation – february 17, 2020 |
5 | Glenmark’s q2 fy 2019-20 results |
6 | Glenmark’s mda q2 fy 2019 – 20 |
7 | Glenmark pharmaceuticals receives anda approval for chlorzoxazone tablets usp, 375 mg and 750 mg; glenmark’s first anda approval out of their new u.s. facility |
Icon | Domain | IP | Alexa Rank |
Lawfulpath.com | 64.22.104.107 | 3.341.956 | |
Startupguys.net | 64.22.104.120 | 186.317 |